Periodic erythroexchange is an effective strategy for high risk paediatric patients with sickle-cell disease

Nicoletta Masera1, Luisa Tavecchia, Lorena Pozzi

  • 1Clinica Pediatrica, Università di Milano-Bicocca, Ospedale San Gerardo, Via Pergolesi 33, Monza 20052, Italy. nicoletta.masera@hsgerardo.org

Insights

Exchange transfusion programs offer effective sickle cell disease management in children, improving quality of life without significant complications. Costs are comparable to chronic transfusion, making it a viable alternative for severe cases.

Area of Science:

  • Hematology
  • Pediatrics
  • Transfusion Medicine

Background:

  • Sickle cell disease (SCD) is a genetic blood disorder requiring effective management strategies.
  • Exchange transfusion is a therapeutic option for SCD complications.
  • Evaluating its long-term efficacy, safety, and cost is crucial.

Purpose of the Study:

  • To assess the efficacy, safety, and cost-effectiveness of exchange transfusion programs in pediatric sickle cell patients.
  • To compare periodic erythroexchange with chronic transfusion regimens.
  • To identify its role in managing severe SCD cases.

Main Methods:

  • Retrospective study over 11 years.
  • Inclusion of 34 pediatric sickle cell patients.
  • Focus on 13 high-risk patients undergoing periodic erythroexchange.

Main Results:

  • Good clinical control and improved quality of life observed.
  • No disease-related complications or significant iron overload reported.
  • Procedure-related side effects were absent, and costs were comparable to chronic transfusion.

Conclusions:

  • Periodic erythroexchange is a safe and effective treatment for severe sickle cell disease in children.
  • It offers a good alternative to chronic transfusion, especially for hydroxyurea-intolerant or non-responsive patients.
  • This program improves patient outcomes and quality of life.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...